Yaden DB

Department of Psychiatry and Behavioral Sciences, Center for Psychedelic and Consciousness Research, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

Yaden DB

An Open-Label Multidose Psilocybin Intervention for Obsessive-Compulsive Disorder

Validating and creating a short-form of the persisting effects questionnaire: A measure of positive and negative outcomes from psychedelic experiences.

Psychedelics Trials and Outcomes- A Closer Look.

Beyond head-twitch response: Acute psilocybin affects spontaneous behaviors in rats in a dose-dependent manner.

Balancing safety and access in Oregon's psilocybin services.

Psilocybin-induced neurocardiogenic syncope: a case report.

Acute Cardiovascular Effects of Psilocybin: A Pooled Analysis of 14 Studies with Safety Recommendations

A living systematic review, meta-analysis, and open data resource of trials of MDMA-assisted therapy for PTSD

Advancing the Field of Psychedelic Epidemiology.

Psychedelic medicine: mechanisms, evidence, and translation to practice.

Trip sitting or just sitting? Session facilitators substantially influence psychedelic experiences in clinical trials but not in healthy ones.

Analyzing the concept of independence in psychedelic research.

Roland R. Griffiths, psychopharmacology pioneer: Abuse liability, alcohol, nicotine, caffeine, benzodiazepines, and psychedelics.

Psychological support can be distinguished from psychotherapy: Clarifications for future empirical work.

Clinical psychedelic research in adolescents: a scoping review and overview of ethical considerations.

Considerations and cautions for the integration of psilocybin into routine clinical care: a consensus statement from the US National Network of Depression Centers' Task Group on Psychedelics and Related Compounds.

Informed Consent Documents from Psychedelic Clinical Trials: A Descriptive Ethical Analysis.

Clinical Psychedelic Therapy Research Involving Adolescents: Protocol for a Scoping Review of Intervention Studies

Insights on psychedelics: A systematic review of therapeutic effects.

Adverse Events Should Not Be Surprising in Psychedelic Research.

A Field-Wide Review and Analysis of Study Materials Used in Psilocybin Trials: Assessment of Two Decades of Research.

On Minimizing Risk and Harm in the Use of Psychedelics.

Developing a short form of the Awe Experience Scale (AWE-SF) in psychedelic samples.

Adverse Events in Studies of Classic Psychedelics: A Systematic Review and Meta-Analysis.

Associations between psychedelic use and cannabis use disorder in a nationally representative sample.

Psilocybin in Bipolar II Study Provides Preliminary Data on Safety.

Narrative review of the potential for psychedelics to treat Prolonged Grief Disorder.

Psychedelic Experiences Increase Mind Perception but do not Change Atheist-Believer Status: A Prospective Longitudinal Study.

Strong Bipartisan Support for Controlled Psilocybin Use as Treatment or Enhancement in a Representative Sample of US Americans: Need for Caution in Public Policy Persists.

Valuing the Acute Subjective Experience.

Innovations in group-based psilocybin-assisted therapy of major depression in patients with cancer.

IUPHAR-review: The integration of classic psychedelics into current substance use disorder treatment models.

Learned Helplessness As a Potential Transdiagnostic Therapeutic Mechanism of Classic Psychedelics.

Naturalistic Psilocybin Use Increases Mind Perception but not Atheist-Believer status: A Prospective Longitudinal Study

Naturalistic Psilocybin Use Increases Mind Perception but not Atheist-Believer status: A Prospective Longitudinal Study

Attenuation of psilocybin mushroom effects during and after SSRI/SNRI antidepressant use.

Reconsidering "dissociation" as a predictor of antidepressant efficacy for esketamine.

Does the trip matter? Investigating the role of the subjective effects of psychedelics in persisting therapeutic effects.

A Bayesian Reanalysis of a Trial of Psilocybin versus Escitalopram for Depression.

Ethical Issues Regarding Nonsubjective Psychedelics as Standard of Care.

The Psychedelic Integration Scales: Tools for Measuring Psychedelic Integration Behaviors and Experiences.

Psychedelics and Psychotherapy: Cognitive-Behavioral Approaches as Default.

Psychedelics and Consciousness: Distinctions, Demarcations, and Opportunities.

Psychedelics in Psychiatry-Keeping the Renaissance From Going Off the Rails.

The Subjective Effects of Psychedelics Are Necessary for Their Enduring Therapeutic Effects.